Maximus, Inc. $MMS Shares Sold by Ruffer LLP

Key Points

• Ruffer LLP reduced its stake in Maximus, Inc. by 26.3% in Q2, now owning 0.19% of the company valued at $7.3 million after selling 37,207 shares.
• Maximus reported a better-than-expected earnings of $2.16 per share for the last quarter, exceeding estimates by $0.77, with revenue of $1.35 billion.
• The company announced a quarterly dividend of $0.30 per share, with a 1.4% yield, and a dividend payout ratio of 22.10%.

Ruffer LLP reduced its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 26.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 104,359 shares of the health services provider's stock after selling 37,207 shares during the period. Ruffer LLP owned 0.19% of Maximus worth $7,326,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of MMS. GAMMA Investing LLC grew its stake in Maximus by 60.4% in the 2nd quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider's stock worth $82,000 after acquiring an additional 442 shares during the period. Avanza Fonder AB grew its stake in Maximus by 17.2% in the 2nd quarter. Avanza Fonder AB now owns 3,233 shares of the health services provider's stock worth $227,000 after acquiring an additional 475 shares during the period. UMB Bank n.a. grew its stake in Maximus by 37.5% in the 2nd quarter. UMB Bank n.a. now owns 833 shares of the health services provider's stock worth $58,000 after acquiring an additional 227 shares during the period. Exchange Traded Concepts LLC grew its stake in Maximus by 2.0% in the 2nd quarter. Exchange Traded Concepts LLC now owns 11,870 shares of the health services provider's stock worth $833,000 after acquiring an additional 228 shares during the period. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in Maximus in the 2nd quarter worth approximately $577,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Stock Performance

Shares of MMS stock opened at $87.77 on Thursday. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The firm has a market capitalization of $4.95 billion, a P/E ratio of 16.16 and a beta of 0.61. The company's fifty day moving average price is $82.57 and its two-hundred day moving average price is $74.28.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company's revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were given a $0.30 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus's dividend payout ratio is 22.10%.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company's stock. According to data from MarketBeat.com, Maximus currently has a consensus rating of "Strong Buy" and a consensus target price of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.